Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Fujiwara

Showing results (471-480 of 497) with videos related to

Pageof 50
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[The IL-6 and COX-2 expression related to sensitivity of chemoradiotherapy and prognosis in esophageal carcinoma]Shinichi Okamura, Hitoshi Fujiwara, Kentaro Suchi, et al.
World Journal of Gastrointestinal Oncology|August 26, 2015
Gastric carcinoma originating from the heterotopic submucosal gastric gland treated by laparoscopy and endoscopy cooperative surgeryTaisuke Imamura, Shuhei Komatsu, Daisuke Ichikawa, et al.
Clinical & Experimental Metastasis|February 24, 2009
NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cellsTakeshi Kubota, Hiroaki Taiyoh, Atsushi Matsumura, et al.
Oncology Reports|June 1, 2013
Interruption of the HGF paracrine loop by NK4, an HGF antagonist, reduces VEGF expression of CT26 cellsTakeshi Kubota, Atsushi Matsumura, Hiroaki Taiyoh, et al.
British Journal of Cancer|December 26, 2023
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancerHajime Kamiya, Shuhei Komatsu, Yusuke Takashima, et al.
International Journal of Cancer|July 10, 2009
Gene transfer of NK4, an angiogenesis inhibitor, induces CT26 tumor regression via tumor-specific T lymphocyte activationTakeshi Kubota, Hiroaki Taiyoh, Atsushi Matsumura, et al.
European Radiology|November 2, 2014
Internal structures of the globus pallidus in patients with Parkinson's disease: evaluation with quantitative susceptibility mapping (QSM)Satoru Ide, Shingo Kakeda, Issei Ueda, et al.
Oncotarget|December 20, 2017
KH-type splicing regulatory protein is involved in esophageal squamous cell carcinoma progressionYuji Fujita, Kiyoshi Masuda, Junichi Hamada, et al.
Journal of Surgical Oncology|July 1, 2021
Oligometastasis scoring system for predicting survival of patients with colorectal liver metastasis after hepatectomyHiroyuki Inoue, Tsutomu Kawaguchi, Hisashi Ikoma, et al.
American Journal of Cancer Research|January 13, 2025
A novel semi-quantitative scoring method for CD8+ tumor-infiltrating lymphocytes based on infiltration sites in gastric cancerYudai Nakabayashi, Jun Kiuchi, Takeshi Kubota, et al.
Pageof 50

Showing results (471-480 of 497) with videos related to

Sort By:
Pageof 50
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[The IL-6 and COX-2 expression related to sensitivity of chemoradiotherapy and prognosis in esophageal carcinoma]Shinichi Okamura, Hitoshi Fujiwara, Kentaro Suchi, et al.
World Journal of Gastrointestinal Oncology|August 26, 2015
Gastric carcinoma originating from the heterotopic submucosal gastric gland treated by laparoscopy and endoscopy cooperative surgeryTaisuke Imamura, Shuhei Komatsu, Daisuke Ichikawa, et al.
Clinical & Experimental Metastasis|February 24, 2009
NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cellsTakeshi Kubota, Hiroaki Taiyoh, Atsushi Matsumura, et al.
Oncology Reports|June 1, 2013
Interruption of the HGF paracrine loop by NK4, an HGF antagonist, reduces VEGF expression of CT26 cellsTakeshi Kubota, Atsushi Matsumura, Hiroaki Taiyoh, et al.
British Journal of Cancer|December 26, 2023
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancerHajime Kamiya, Shuhei Komatsu, Yusuke Takashima, et al.
International Journal of Cancer|July 10, 2009
Gene transfer of NK4, an angiogenesis inhibitor, induces CT26 tumor regression via tumor-specific T lymphocyte activationTakeshi Kubota, Hiroaki Taiyoh, Atsushi Matsumura, et al.
European Radiology|November 2, 2014
Internal structures of the globus pallidus in patients with Parkinson's disease: evaluation with quantitative susceptibility mapping (QSM)Satoru Ide, Shingo Kakeda, Issei Ueda, et al.
Oncotarget|December 20, 2017
KH-type splicing regulatory protein is involved in esophageal squamous cell carcinoma progressionYuji Fujita, Kiyoshi Masuda, Junichi Hamada, et al.
Journal of Surgical Oncology|July 1, 2021
Oligometastasis scoring system for predicting survival of patients with colorectal liver metastasis after hepatectomyHiroyuki Inoue, Tsutomu Kawaguchi, Hisashi Ikoma, et al.
American Journal of Cancer Research|January 13, 2025
A novel semi-quantitative scoring method for CD8+ tumor-infiltrating lymphocytes based on infiltration sites in gastric cancerYudai Nakabayashi, Jun Kiuchi, Takeshi Kubota, et al.
Pageof 50